Cuorips Inc. (TYO:4894)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024
Regenerative Medicine Products	212.00M	175.00M	23.00M
Total	212.00M	175.00M	23.00M

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024
Japan	212.00M	175.00M	23.00M
Total	212.00M	175.00M	23.00M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error